Chronic fatigue syndrome patients have no reason to accept the PACE trial results: Response to Keith J Petrie and John Weinman.
Agardy S. (2017) Chronic fatigue syndrome patients have no reason […]
Research Papers
Discernment of mediator and outcome measurement in the PACE trial.
Discernment of mediator and outcome measurement in the PACE trial. Read More »
Carr E et al. (2021) Discernment of mediator and outcome
PACE team response shows a disregard for the principles of science.
PACE team response shows a disregard for the principles of science. Read More »
Edwards J. (2017) PACE team response shows a disregard for
Further commentary on the PACE trial: Biased methods and unreliable outcomes.
Further commentary on the PACE trial: Biased methods and unreliable outcomes. Read More »
Geraghty KJ. (2017) Further commentary on the PACE trial: Biased
Bias, misleading information and lack of respect for alternative views have distorted perceptions of myalgic encephalomyelitis/chronic fatigue syndrome and its treatment.
Goudsmit E and Howes S. (2017) Bias, misleading information and
The PACE trial missteps on pacing and patient selection.
The PACE trial missteps on pacing and patient selection. Read More »
Jason LA. (2017) The PACE trial missteps on pacing and
PACE investigators’ response is misleading regarding patient survey results.
PACE investigators’ response is misleading regarding patient survey results. Read More »
Krike KD. (2017) PACE investigators’ response is misleading regarding patient
Defense of the PACE trial is based on argumentation fallacies.
Defense of the PACE trial is based on argumentation fallacies. Read More »
Lubet S. (2017) Defense of the PACE trial is based
Investigator bias and the PACE trial.
Investigator bias and the PACE trial. Read More »
Lubet S. (2017) Investigator bias and the PACE trial. Journal
Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.
Castro-Marrero J et al. (2017) Treatment and management of chronic
Acceptance and identity change: An interpretative phenomenological analysis of carers’ experiences in myalgic encephalopathy/chronic fatigue syndrome.
Catchpole S and Garip G (2019) Acceptance and identity change:
Environmental accommodations for university students affected by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Chu L et al. (2020) Environmental accommodations for university students
What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.
Clery P et al . (2022) What treatments work for
Chronic fatigue syndrome (CFS/ME) symptom-based phenotypes and 1-year treatment outcomes in two clinical cohorts of adult patients in the UK and The Netherlands.
Collin SM et al. (2018) Chronic fatigue syndrome (CFS/ME) symptom-based
Specialist treatment of chronic fatigue syndrome/ME: a cohort study among adult patients in England.
Collin SM. and Crawley E . (2017) Specialist treatment of
Clinical and cost-effectiveness of the Lightning Process in addition to specialist medical care for paediatric chronic fatigue syndrome: randomised controlled trial.
Crawley EM et al. (2017) Clinical and cost-effectiveness of the
A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study.
A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. Read More »
Daniels J and Loades ME. (2017) A Novel Approach to
Illness beliefs and treatment outcome in chronic fatigue syndrome.
Illness beliefs and treatment outcome in chronic fatigue syndrome. Read More »
Deale A et al. (1998) Illness beliefs and treatment outcome
Approaching recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Challenges to consider in research and practice.
Devendorf AR et al. (2017) Approaching recovery from myalgic encephalomyelitis
Medical Care Situation of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Germany.
Froehlich L et al. (2021) Medical Care Situation of People